Géoméga reçoit 1,235 M $ de l'exercice de bons de souscription et d'autres instruments
10 mai 2022 07h10 HE
|
Ressources Géoméga Inc.
Position financière à son meilleur pour générer des investissements records dans les applications de R&D commercialesPlus de 5,1 M $ en trésorerie et équivalents de trésorerieFacilité d'emprunt de...
Geomega Receives $1.235M from Exercise of Warrants and Other Instruments
10 mai 2022 07h10 HE
|
Geomega Resources Inc.
Strongest ever financial position to drive record investments in commercial R&D applicationsOver $5.1M in cash and cash equivalents$3M interest-free debt facility fully available from IQ for REE...
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
19 avr. 2022 15h15 HE
|
The Rosen Law Firm PA
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
BTCS Retires Convertible Note Early, Eliminates Potential Equity Dilution
27 sept. 2021 09h21 HE
|
BTCS Inc.
Silver Spring, MD, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology focused company, is pleased to announce that the Company has paid...
2020 Half-year results: Stronger financial position and research programs moving forward despite the international context
01 oct. 2020 12h30 HE
|
Deinove
2020 Half-year results: Stronger financial position and research programs moving forward despite the international context Clinical program for the antibiotic candidate DNV3837 continues, with the...
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
07 nov. 2019 07h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
Phase 3 “RESOLVE-1” study of lenabasum for treatment of systemic sclerosis on track for topline results in summer of 2020Systemic sclerosis is a rare autoimmune disease affecting ~200,000 people in...
Update Announcement regarding fundraising and financial position
18 févr. 2019 12h00 HE
|
Gate Ventures Plc
Gate Ventures PLCUpdate Announcement regarding fundraising and financial positionISIN Number: GB00BYX2WP92TICKER: GATEGate Ventures PLCPress ReleaseFebruary 18, 2019 Gate Ventures PLC ("Gate...